UBE2I and cervical carcinoma: Abolishing GATA4 sumoylation by mutating the SUMO acceptor K365 or interfering with GATA4 sumoylation by knocking down the obligatory SUMO E2 conjugase, Ubc9, prevented GATA4 nuclear localization in HeLa cervical carcinoma cells.